8 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital
In this article, we discuss the 8 stocks to buy according to Devesh Gandhi's SilverArc Capital based on Q1 holdings of the fund.
Immunogen Inc. (IMGN)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 21,741,458 | $103,489 | +8% | 2.25% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 11,586,193 | $55,150 | +13% | 0.1% |
| 3. | Redmile Group Jeremy Green | 9,217,945 | $43,877 | +12% | 1.36% |
| 4. | Millennium Management Israel Englander | 3,500,017 | $16,660 | -31% | 0% |
| 5. | Deerfield Management James E. Flynn | 3,470,675 | $16,520 | 0.36% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.76 | 30,000 | Director | 53,800 | 2018-11-06 | Filing | |
| $1.80 | 20,000 | Director | 23,800 | 2016-12-15 | Filing | |
| $1.83 | 25,000 | Officer, Director | 100,100 | 2016-11-08 | Filing | |
| $1.78 | 16,600 | Officer | 39,231 | 2016-11-02 | Filing | |
| $1.71 | 10,000 | Officer | 31,100 | 2016-11-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.38 | 11,052 | Officer | 37,912 | 2020-12-31 | Filing | |
| $3.43 | 5,448 | Officer | 21,382 | 2020-04-02 | Filing | |
| $4.99 | 16,790 | Officer | 75,624 | 2020-02-24 | Filing | |
| $4.99 | 55,222 | Officer, Director | 433,776 | 2020-02-24 | Filing | |
| $4.99 | 25,803 | Officer | 98,089 | 2020-02-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 187,126 | $890,720 | 0% | |
| 2. | 31,443 | $149,669 | 0% | |
| 3. | 16,432,933 | $78,225 | 0% | |
| 4. | 15,478,516 | $73,678 | 0% | |
| 5. | 13,707,389 | $65,247 | 0% |
News See All
10 Best Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
In this piece, we will take a look at the ten best stocks to buy under $20 according to Jeremy Green's Redmile Group.
Why These 5 Stocks Are in the Spotlight on Monday
In this article, we take a look at five stocks that are in the spotlight on Monday.
10 Cheap Growth Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 10 cheap growth stocks to buy according to billionaire Steve Cohen.
Where Does The Smart Money Stand On ImmunoGen, Inc. (IMGN)?
In this article we will check out the progression of hedge fund sentiment towards ImmunoGen, Inc. (NASDAQ:IMGN) and determine whether it is a good investment right now.
5 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio
In this article, we discuss the 5 growth stocks under $20 in billionaire Ken Fisher's portfolio.
5 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
In this article, we discuss the 5 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Hedge Funds Are Crazy About ImmunoGen, Inc. (IMGN)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of June.
Hedge Funds Are Crazy About ImmunoGen, Inc. (IMGN)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Is IMGN Stock A Buy or Sell?
At Insider Monkey, we pore over the filings of nearly 887 top investment firms every quarter, a process we have now completed for the latest reporting period.
Billionaire Hedge Funds
